Show items per page
Elements: 111
Page 4 on 6
 TitleAuthors / EditorsDate
add to browser selection
Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery Rubbia-Brandt, Laura; Giostra, Emiliano; Brezault, C; Roth, Arnaud; ... Terris, B 2007
add to browser selection
Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research Roth, Arnaud; Fazio, Nicola; Stupp, Roger; Falk, Stephen; ... de Braud, Filippo 2007
add to browser selection
Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma Weder, W; Stahel, R A; Bernhard, J; Bodis, S; ... Spiliopoulos, Anastase 2007
add to browser selection
The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006 Verslype, C; Van Cutsem, E; Dicato, M; Cascinu, S; ... Zalcberg, J 2007
add to browser selection
A randomised phase II study of OSI-7904L versus 5-fluorouracil (FU)/leucovorin (LV) as first-line treatment in patients with advanced biliary cancers Ciuleanu, T; Diculescu, M; Hoepffner, N M; Trojan, J; ... Philip, P A 2007
add to browser selection
Response from authors: Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary (Br J Surg 2006; 93: 872-878) Mentha, Gilles; Majno, Pietro; Allal, Abdelkarim Said; Roth, Arnaud 2007
add to browser selection
Treatment strategies for the management of advanced colorectal liver metastases detected synchronously with the primary tumour Mentha, Gilles; Majno, Pietro; Terraz, Sylvain; Rubbia-Brandt, Laura; ... Roth, Arnaud 2007
add to browser selection
The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005 Van Cutsem, E; Dicato, M; Arber, N; Benson, A; ... van de Velde, C 2006
add to browser selection
Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study Betticher, D C; Hsu Schmitz, S-F; Totsch, Martin; Hansen, E; ... Ris, H-B 2006
add to browser selection
Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary Mentha, Gilles; Majno, Pietro; Andres, Axel; Rubbia-Brandt, Laura; ... Roth, Arnaud 2006
add to browser selection
Complete closure of cancer-related anovaginal and anoperineal fistulas in locally advanced anal canal carcinomas by upfront intra-arterial chemotherapy followed by combined radiochemotherapy: report of two cases Rosset, L; Allal, Abdelkarim Said; Morel, Philippe; Roche, Bruno; Roth, Arnaud 2006
add to browser selection
Authors' reply: Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary (Br J Surg) 2006; 93; 872–878 Mentha, Gilles; Majno, Pietro; Roth, Arnaud 2006
add to browser selection
Assessment of quality of life in patients with rectal cancer treated by preoperative radiotherapy: a longitudinal prospective study Allal, Abdelkarim Said; Gervaz, Pascal; Gertsch, Philippe; Bernier, Jacques; ... Bieri, Sabine 2005
add to browser selection
Preoperative concomitant hyperfractionated radiotherapy and gemcitabine for locally advanced rectal cancers: a phase I-II trial Allal, Abdelkarim Said; Bieri, Sabine; Gervaz, Pascal; Soravia, Claudio; ... Roth, Arnaud 2005
add to browser selection
Neoadjuvant radiochemotherapy for locally advanced gastric cancer: long-term results of a phase I trial Allal, Abdelkarim Said; Zwahlen, Daniel; Brundler, Marie-Anne; De Peyer, Raymond; ... Roth, Arnaud 2005
add to browser selection
Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I-II study Seium Neberay, Yodit; Stupp, R; Ruhstaller, T; Gervaz, Pascal; ... Roth, Arnaud 2005
add to browser selection
Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II study Van Cutsem, E; Dirix, L; Van Laethem, J-L; Van Belle, S; ... Bleiberg, H 2005
add to browser selection
Nouveaux traitements systémiques dans le cancer du pancréas avancé : implications sur la survie et considérations médicoéconomiques Mazzuri, Sebastien; Roth, Arnaud 2005
add to browser selection
A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity Borner, M M; Bernhard, Jacqueline Simone; Dietrich, D.; Popescu, R; ... Roth, Arnaud 2005
add to browser selection
Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer Rubbia-Brandt, Laura; Audard, V; Sartoretti, Pascal Daniel; Roth, Arnaud; ... Terris, B 2004
| 1 | 2 | 3 | 4 | 5 | 6 |